Recommended Intravenous Dose of Diclofenac for Adults
The recommended IV dose of diclofenac for adults is 37.5 mg administered as an intravenous bolus injection every 6 hours, not to exceed 150 mg per day. 1
Dosing Details
The FDA-approved formulation (HPβCD diclofenac) allows for direct IV bolus administration without requiring dilution or prolonged infusion. Key dosing parameters include:
- Standard dose: 37.5 mg IV bolus every 6 hours
- Alternative lower dose: 18.75 mg IV bolus every 6 hours (for patients requiring lower exposure)
- Maximum daily dose: 150 mg/day
- Administration: Direct IV bolus injection (no dilution required with newer formulations)
- Duration: Use the lowest effective dose for the shortest duration necessary 1
Clinical Evidence Supporting This Dosing
Both 18.75 mg and 37.5 mg doses demonstrated significant analgesic efficacy in postoperative pain management. 2 In a multicenter phase 3 trial of 331 patients with moderate-to-severe pain after abdominal or pelvic surgery, both doses provided:
- Significant pain intensity reduction over 48 hours compared to placebo (P < 0.05)
- Significant reduction in rescue morphine requirements (P < 0.0001)
- Similar efficacy to ketorolac 30 mg IV
The 37.5 mg dose showed slightly superior pain relief compared to 18.75 mg, with 66% of patients achieving at least 50% pain relief versus 57% with the lower dose 3. However, both doses were effective and well-tolerated.
Important Clinical Considerations
Cardiovascular and gastrointestinal risks: Like all NSAIDs, IV diclofenac carries black box warnings for increased risk of serious cardiovascular thrombotic events (MI, stroke) and serious GI adverse events (bleeding, ulceration, perforation) 4, 1. These risks may increase with duration of use and are higher in patients with existing cardiovascular disease.
Contraindications:
- Perioperative pain in CABG surgery setting
- Advanced renal impairment (dose adjustment required for creatinine clearance 10-30 mL/min)
- Active GI bleeding or ulceration
- Pregnancy at ≥30 weeks gestation 1
Advantages of IV formulation: The newer HPβCD formulation allows rapid bolus administration (versus 30-120 minute infusion required for older formulations), with faster onset of analgesia and lower incidence of thrombophlebitis 5, 2.
Duration of therapy: Limit to short-term use (typically 2-5 days postoperatively) and transition to oral NSAIDs or alternative analgesics as soon as clinically appropriate to minimize NSAID-related risks 1.